Immune system modulation via gradual exposure to hen's egg proteins (null)

"Immune system modulation via gradual exposure to hen's egg proteins" refers to the clinical approach—most commonly called oral immunotherapy (OIT)—which involves the consumption of gradually increasing, controlled doses of egg protein by egg-allergic individuals, with the goal of inducing immune tolerance. OIT exploits the fact that exposure to denatured (heated or baked) egg proteins is less allergenic, allowing many patients to tolerate these forms even when they react to raw egg[4][8]. Key immunological changes during successful therapy include a rise in regulatory cytokines such as interleukin-10 (IL-10) and a drop in Th2-associated cytokines (IL-4, IL-5), with an overall reduction in allergen-specific IgE responses[2][4]. The process is complex and patient-specific, and is not free of risks, primarily due to the potential for severe allergic reactions during treatment. There is currently no single molecular target; rather, the approach reorients whole immune pathways involving both B-cell and T-cell regulatory mechanisms[2][3][4]. In summary, this is not a molecular drug target, receptor, or enzyme, but a clinical immunotherapeutic strategy. Further specification (e.g., to individual egg allergen molecules such as ovalbumin or ovomucoid) would be required to map to a conventional molecular target record[3][4][7][8].

Other names

oral immunotherapy to egg proteinOIT (egg)gradual egg desensitizationegg protein desensitizationfood allergy immunotherapy (egg)

Gradual exposure to egg allergens shifts immune response from a Th2/IgE-dominated response (allergic) to a more regulatory, tolerant profile (including enhanced IL-10 and reduced IL-4/IL-5). Promotes immune deviation and/or anergy toward egg antigens. Decreases allergen-specific IgE reactivity over time in many patients.